|
Neuropeptide Y, human, Free Acid
|
PRO-ALA-GLU-ASP-MET-ALA-ARG-TYR-TYR-SER-ALA-LEU-ARG-HIS-TYR-ILE-ASN-LEU-ILE-THR-ARG-GLN-ARG-TYR-NH2: PAEDMARYYSALRHYINLITRQRY-NH2
|
|
|
Neuropeptide Y, human, rat, [D-Trp32]-
|
NEUROPEPTIDE Y, HUMAN, RAT, [D-TRP32]-
|
|
|
Neuropeptide Y, human, rat, [Leu31,Pro34]-
|
NEUROPEPTIDE Y, HUMAN, RAT, [LEU31,PRO34]-
|
|
|
Neuropeptide Y, human, rat, Biotinyl-
|
NEUROPEPTIDE Y, HUMAN, RAT, BIOTINYL-
|
|
|
Myristoylated ADP - Ribosylation Factor 6, myr - ARF6 (2 - 13)
|
MYRISTOYL -GLY-LYS-VAL-LEU-SER-LYS-ILE-PHE-GLY-ASN-LYS-GLU
|
|
|
Myristoylated Protein Kinase C (19-31)
|
MYRISTOYL-ARG-PHE-ALA-ARG-LYS-GLY-ALA-LEU-ARG-GLN-LYS-ASN-VAL
|
|
|
Myristoyl-Lys-Arg-Thr-Leu-Arg-OH
|
MYRISTOYL-LYS-ARG-THR-LEU-ARG
|
125678-68-4
|
|
Myristoyl-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-OH
|
MYRISTOYL-PHE-ALA-ARG-LYS-GLY-ALA-LEU-ARG-GLN-OH
|
147217-25-2
|
|
N-((RS)-2-Hydroxy-1-phenyl-ethyl)-Val-Leu-anilide
|
N-((RS)-2-HYDROXY-1-PHENYL-ETHYL)-VAL-LEU-ANILIDE
|
283159-27-3
|
|
N-((RS)-2-Hydroxy-2-phenyl-ethyl)-Val-Leu-anilide
|
N-((RS)-2-HYDROXY-2-PHENYL-ETHYL)-VAL-LEU-ANILIDE
|
282732-35-8
|
|
N-((RS)-2-Hydroxy-propyl)-Val-Leu-anilide
|
N-((RS)-2-HYDROXY-PROPYL)-VAL-LEU-ANILIDE
|
282726-24-3
|
|
N-((RS)-3-Chloro-2-hydroxy-propyl)-Val-Leu-anilide
|
N-((RS)-3-CHLORO-2-HYDROXY-PROPYL)-VAL-LEU-ANILIDE
|
282726-25-4
|
|
Neuropeptide Y, porcine;YPSKPDNPGEDAPAEDLARYYSALRHYINLITRQRY-NH2
|
豬源神經(jīng)肽Y
|
82785-45-3
|
|
Neuropeptide Y (NPY) and Related Peptides
|
NEUROPEPTIDE Y (NPY) AND RELATED PEPTIDES
|
|
|
Neuropeptide Y (human, rat) Acetate 200 μg/vial (Clinalfa basic)
|
NEUROPEPTIDE Y (HUMAN, RAT) ACETATE 200 ΜG/VIAL (CLINALFA BASIC)
|
|
|
Neuropeptide Y, human, rat;YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY-NH2
|
NEUROPEPTIDE Y (FREE ACID) (HUMAN, RAT)
|
99575-89-0
|
|
Neuropeptide Y (free acid) (human)
|
TYR-PRO-SER-LYS-PRO-ASP-ASN-PRO-GLY-GLU-ASP-ALA-PRO-ALA-GLU-ASP-MET-ALA-ARG-TYR-TYR-SER-ALA-LEU-ARG-HIS-TYR-ILE-ASN-LEU-ILE-THR-ARG-GLN-ARG-TYR
|
|
|
Neuropeptide Y (3-36), porcine;SKPDNPGEDAPAEDLARYYSALRHYINLITRQRY-NH2
|
SER-LYS-PRO-ASP-ASN-PRO-GLY-GLU-ASP-ALA-PRO-ALA-GLU-ASP-LEU-ALA-ARG-TYR-TYR-SER-ALA-LEU-ARG-HIS-TYR-ILE-ASN-LEU-ILE-THR-ARG-GLN-ARG-TYR-NH2
|
143863-88-1
|
|
Neuropeptide Y (3-36), human, rat;SKPDNPGEDAPAEDMARYYSALRHYINLITRQRY-NH2
|
NEUROPEPTIDE Y (3-36) (HUMAN, RAT)
|
150138-78-6
|
|
Neuropeptide Y (27-36), [D-Tyr27&36,D-Thr32]-
|
NEUROPEPTIDE Y (27-36), [D-TYR27&36,D-THR32]-
|
|
|
Neuropeptide Y (2-36), porcine;PSKPDNPGEDAPAEDLARYYSALRHYINLITRQRY-NH2
|
NEUROPEPTIDE Y (2-36) (PORCINE)
|
102961-52-4
|
|
Neuropeptide Y (2-36), human, rat;PSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY-NH2
|
NEUROPEPTIDE Y (2-36) (HUMAN, RAT)
|
123139-39-9
|
|
Neuropeptide Y (22-36), porcine;SALRHYINLITRQRY-NH2
|
SER-ALA-LEU-ARG-HIS-TYR-ILE-ASN-LEU-ILE-THR-ARG-GLN-ARG-TYR-NH2
|
119019-65-7
|
|
Neuropeptide Y (13-36), porcine, [Leu31,Pro34]-
|
NEUROPEPTIDE Y (13-36), PORCINE, [LEU31,PRO34]-
|
|
|
Neuropeptide Y (13-36), human, rat, [Leu31,Pro34]-
|
NEUROPEPTIDE Y (13-36), HUMAN, RAT, [LEU31,PRO34]-
|
|
|
Neuropeptide Y(13-36), porcine;PAEDLARYYSALRHYINLITRQRY-NH2
|
PRO-ALA-GLU-ASP-LEU-ALA-ARG-TYR-TYR-SER-ALA-LEU-ARG-HIS-TYR-ILE-ASN-LEU-ILE-THR-ARG-GLN-ARG-TYR-NH2
|
113662-54-7
|
|
Neuropeptide Y (13-36), human, rat;PAEDMARYYSALRHYINLITRQRY-NH2
|
NEUROPEPTIDE Y (13-36) (HUMAN, RAT)
|
122341-40-6
|
|
Neuropeptide Y (1-24) amide, human, rat;YPSKPDNPGEDAPAEDMARYYSAL-NH2
|
TYR-PRO-SER-LYS-PRO-ASP-ASN-PRO-GLY-GLU-ASP-ALA-PRO-ALA-GLU-ASP-MET-ALA-ARG-TYR-TYR-SER-ALA-LEU-NH2
|
131448-51-6
|
|
Neuropeptide W-30 (rat)
|
TRP-TYR-LYS-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-THR-VAL-GLY-ARG-ALA-SER-GLY-LEU-LEU-MET-GLY-LEU-ARG-ARG-SER-PRO-TYR-LEU-TRP
|
383415-90-5
|
|
Neuropeptide W-30 (human)
|
神經(jīng)肽W-30 (人)
|
383415-80-3
|
|
Neuropeptide W-23 (rat)
|
TRP-TYR-LYS-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-THR-VAL-GLY-ARG-ALA-SER-GLY-LEU-LEU-MET-GLY-LEU
|
383415-89-2
|
|
Neuropeptide W-23 (human)
|
TRP-TYR-LYS-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-THR-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU
|
383415-79-0
|
|
Neuropeptide VF (56-92) (human)
|
NEUROPEPTIDE VF (56-92) (HUMAN)
|
381006-66-2
|
|
Neuropeptide VF (124-131) (human)
|
NEUROPEPTIDE VF (124-131) (HUMAN)
|
311309-27-0
|
|
Neuropeptide SF (human)
|
NEUROPEPTIDE SF (HUMAN)
|
192387-39-6
|
|
Neuropeptide SF
|
NEUROPEPTIDE SF
|
|
|
Neuropeptide S, NPS, rat;SFRNGVGSGVKKTSFRRAKQ
|
NEUROPEPTIDE S (RAT)
|
412938-75-1
|
|
Neuropeptide S, NPS, human;SFRNGVGTGMKKTSFQRAKS
|
NEUROPEPTIDE S (HUMAN)
|
412938-67-1
|
|
Neuropeptide S (1-10) (human)
|
NEUROPEPTIDE S (1-10) (HUMAN)
|
904910-39-0
|
|
Neuropeptide GE
|
NEUROPEPTIDE GE
|
134748-04-2
|
|
Neuropeptide Y, porcine, [D-Trp32]-
|
NEUROPEPTIDE Y, PORCINE, [D-TRP32]-
|
|
|
Neuropeptide Y, porcine, [Leu31,Pro34]-
|
NEUROPEPTIDE Y, PORCINE, [LEU31,PRO34]-
|
|
|
Neuropeptide Y, porcine, [Pro34]-
|
NEUROPEPTIDE Y, PORCINE, [PRO34]-
|
|
|
Neuropeptide Y, porcine, Biotinyl-
|
NEUROPEPTIDE Y, PORCINE, BIOTINYL-
|
|
|
Neuropeptide Y, porcine, Free Acid
|
PRO-SER-LYS-PRO-ASP-ASN-PRO-GLY-GLU-ASP-ALA-PRO-ALA-GLU-ASP-LEU-ALA-ARG-TYR-TYR-SER-ALA-LEU-ARG-HIS-TYR-ILE-ASN-LEU-ILE-THR-ARG-GLN-ARG-TYR-NH2: PSKPDNPGEDAPAEDLARYYSALRHYINLITRQRY-NH2
|
|
|
Neuropeptide Y(18-36), porcine;ARYYSALRHYINLITRQRY-NH2
|
TYR-PRO-SER-LYS-PRO-ASP-ASN-PRO-GLY-GLU-ASP-ALA-PRO-ALA-GLU-ASP-MET-ALA-ARG-TYR-TYR-SER-ALA-LEU-ARG-HIS-TYR-ILE-ASN-LEU-ILE-THR-ARG-GLN-ARG-TYR: YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY
|
98264-90-5
|
|
Neuropeptide γ
|
NEUROPEPTIDE Γ
|
|
|
Neurotensin;Pyr-LYENKPRRPYIL
|
煙酰胺腺呤二核苷磷酸鈉
|
55508-42-4
|
|
Neurotensin (1-8)
|
神經(jīng)降壓素Neurotensin (1-8)
|
80887-44-1
|
|
Neurotensin (Frog)
|
PYR-SER-HIS-ILE-SER-LYS-ALA-ARG-ARG-PRO-TYR-ILE-LEU-NH2
|
|
|
Neuronostatin-13 (human, canine, porcine)
|
NEURONOSTATIN-13 (HUMAN, CANINE, PORCINE)
|
|
|
Neuronostatin-13 (mouse, rat)
|
NEURONOSTATIN-13 (MOUSE, RAT)
|
|
|
Neuronostatin-19 (human, canine, porcine)
|
Neuronostatin-19 (human, canine, porcine)
|
1872435-06-7
|
|
Neuronostatin-19 (mouse, rat)
|
NEURONOSTATIN-19 (MOUSE, RAT)
|
|
|
Neuropeptide AF
|
NEUROPEPTIDE AF
|
|
|
Neuropeptide AF (human)
|
神經(jīng)肽AF（人類）
|
192387-38-5
|
|
Neuropeptide F;PDKDFIVNPSDLVLDNKAALRDYLRQINEYFAIIGRPRF-NH2
|
PRO-ASP-LYS-ASP-PHE-ILE-VAL-ASN-PRO-SER-ASP-LEU-VAL-LEU-ASP-ASN-LYS-ALA-ALA-LEU-ARG-ASP-TYR-LEU-ARG-GLN-ILE-ASN-GLU-TYR-PHE-ALA-ILE-ILE-GLY-ARG-PRO-ARG-PHE-NH2
|
136697-70-6
|
|
Neuropeptide FF Morphine Modulating Neuropeptide F-8-F-NH2
|
神經(jīng)肽-FF
|
99566-27-5
|
|
Neuropeptide FF Morphine Modulating Neuropeptide
|
PHE-LEU-PHE-GLN-PRO-GLN-ARG-PHE-NH2: FLFQPQRF-NH2
|
|
|
Neuropeptide FF-amide
|
NEUROPEPTIDE FF-AMIDE
|
|
|
N-(2-Carbamoyl-ethyl)-Val-Leu-anilide
|
N-(2-CARBAMOYL-ETHYL)-VAL-LEU-ANILIDE
|
282725-67-1
|
|
N-(Cyanur-2-yl)-Asp-Ala-anilide
|
N-(CYANUR-2-YL)-ASP-ALA-ANILIDE
|
|
|
N(p-Tosyl)-GPR-pNA
|
N(P-TOSYL)-GLY-PRO-ARG-PNA
|
|
|
N,S-Bis-Fmoc-glutathione
|
N-[S-[(9H-芴-9-基甲氧基)羰基]-N-[N-[(9H-芴-9-基甲氧基)羰基]-L-GAMMA-谷氨酰]-L-半胱氨酰]甘氨酸
|
149438-56-2
|
|
N-[(2RS,3RS)-2,3,4-Trihydroxy-butyl]-Val-Leu-anilide
|
N-[(2RS,3RS)-2,3,4-TRIHYDROXY-BUTYL]-VAL-LEU-ANILIDE
|
1926163-76-9
|
|
N-[(RS)-1-Carboxy-3-phenyl-propyl]-Ala-Ala-Phe-4-Abz-OH
|
N-[(RS)-1-CARBOXY-3-PHENYL-PROPYL]-ALA-ALA-PHE-4-ABZ-OH
|
|
|
N-[(RS)-2-Carbamoyl-2-hydroxy-ethyl]-Val-Leu-anilide
|
N-[(RS)-2-CARBAMOYL-2-HYDROXY-ETHYL]-VAL-LEU-ANILIDE
|
1926163-77-0
|
|
N1-Glutathionyl-spermidine disulfide
|
N1-GLUTATHIONYL-SPERMIDINE DISULFIDE
|
108081-77-2
|
|
N-2-Aminoethyl-Val-Leu-anilide
|
N-2-AMINOETHYL-VAL-LEU-ANILIDE
|
282732-36-9
|
|
N-2-Chloroethyl-Val-Leu-anilide
|
N-2-CHLOROETHYL-VAL-LEU-ANILIDE
|
282729-48-0
|
|
N-2-Cyanoethyl-Val-Leu-anilide
|
N-2-CYANOETHYL-VAL-LEU-ANILIDE
|
194351-52-5
|
|
N-2-Ethoxyethyl-Val-Ala-anilide
|
N-2-ETHOXYETHYL-VAL-ALA-ANILIDE
|
194351-51-4
|
|
N-2-Hydroxyethyl-Val-Leu-anilide
|
N-2-HYDROXYETHYL-VAL-LEU-ANILIDE
|
194351-53-6
|
|
Nazumamide A
|
NAZUMAMIDE A
|
138949-86-7
|
|
N-cis-2,6-Dimethylpiperidinocarbonyl-β-tBu-Ala-D-Trp(1-methoxycarbonyl)-D-Nle-OH
|
N-CIS-2,6-DIMETHYLPIPERIDINOCARBONYL-Β-TBU-ALA-D-TRP(1-METHOXYCARBONYL)-D-NLE-OH
|
|
|
Nectofibrin Hexapeptide (rat)
|
TRP-THR-VAL-PRO-THR-ALA
|
123402-49-3
|
|
Neoendorphin (1-5), α-
|
NEOENDORPHIN (1-5), Α-
|
|
|
Neo-Kyotorphin
|
THR-SER-LYS-TYR-ARG
|
83759-54-0
|
|
Nephilatoxin NPTX-11
|
NEPHILATOXIN NPTX-11
|
119613-54-6
|
|
Nephilatoxin NPTX-9
|
NEPHILATOXIN NPTX-9
|
114355-42-9
|
|
Nesfatin-1 (human)
|
Nesfatin-1 (human)
|
917528-35-9
|
|
Nesfatin-1 (mouse)
|
Nesfatin-1 (mouse)
|
917528-36-0
|
|
Nesfatin-1 (rat)
|
Nesfatin-1 (rat)
|
917528-37-1
|
|
Ne-Trifluoroacetyl-L-lysine
|
三氟乙酰賴氨酸
|
10009-20-8
|
|
N-Et-Val-Leu-anilide
|
N-ET-VAL-LEU-ANILIDE
|
282726-22-1
|
|
Neuroendocrine Regulatory Peptide-1 (human)
|
NEUROENDOCRINE REGULATORY PEPTIDE-1 (HUMAN)
|
954420-50-9
|
|
Neuroendocrine Regulatory Peptide-1 (rat)
|
NEUROENDOCRINE REGULATORY PEPTIDE-1 (RAT)
|
954420-51-0
|
|
Neuroendocrine Regulatory Peptide-2 (human)
|
NEUROENDOCRINE REGULATORY PEPTIDE-2 (HUMAN)
|
|
|
Neuroendocrine Regulatory Peptide-2 (rat)
|
NEUROENDOCRINE REGULATORY PEPTIDE-2 (RAT)
|
|
|
Neurokinin A: Substance K: Neuromedin L: NKA;HKTDSFVGLM-NH2
|
神經(jīng)激肽A
|
86933-74-6
|
|
Neurokinin A (4-10), [?-Ala8]-
|
NEUROKININ A (4-10), [-ALA8]-
|
|
|
Neurokinin Receptor (393-407), rat;KTMTESSFYSNMLA
|
LYS-THR-MET-THR-GLU-SER-SER-PHE-TYR-SER-ASN-MET-LEU-ALA
|
|
|
Neurokinins, Neuromedins, Other Tachykinins and Related Peptides
|
NEUROKININS, NEUROMEDINS, OTHER TACHYKININS AND RELATED PEPTIDES
|
|
|
Neuromedin (U-25), porcine;FKVDEEFQGPIVSQNRRYFLFRPRN-NH2
|
豬神經(jīng)調(diào)節(jié)肽U-25
|
98395-76-7
|
|
Neuromedin (U-8), porcine;YFLFRPRN-NH2
|
豬神經(jīng)調(diào)節(jié)肽U-8
|
98395-75-6
|
|
Neuromedin N;KIPYIL-NH2
|
LYS-ILE-PRO-TYR-ILE-LEU
|
92169-45-4
|
|
Neuromedin S, human??;ILQRGSGTAAVDFTKKDHTATWGRPFFLFRPRN-NH2
|
Neuromedin S (human)
|
1138204-27-9
|
|
Neuromedin S (rat)
|
LEU-PRO-ARG-LEU-LEU-HIS-THR-ASP-SER-ARG-MET-ALA-THR-ILE-ASP-PHE-PRO-LYS-LYS-ASP-PRO-THR-THR-SER-LEU-GLY-ARG-PRO-PHE-PHE-LEU-PHE-ARG-PRO-ARG-ASN-NH2
|
843782-19-4
|
|
Neuromedin U, rat;YKVNEYQGPVAPSGGFFLFRPRN-NH2
|
TYR-LYS-VAL-ASN-GLU-TYR-GLN-GLY-PRO-VAL-ALA-PRO-SER-GLY-GLY-PHE-PHE-LEU-PHE-ARG-PRO-ARG-ASN-NH2
|
117505-80-3
|
|
Neuromedin U-23 (rat)
|
NEUROMEDIN U-23 (RAT)
|
|